Advertisement
Loading...

Nuvation Bio Inc.

NUVB-WT•NYSE
Healthcare
Biotechnology
$0.07
$-0.00(-2.53%)
U.S. Market opens in 30h 27m

Nuvation Bio Inc. (NUVB-WT) Stock Overview

Explore Nuvation Bio Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap24.1M
P/E Ratio-11.32
EPS (TTM)N/A
ROE-0.44%
Fundamental Analysis

AI Price Forecasts

1 Month$0.20
3 Months$0.09
1 Year Target$0.30

NUVB-WT Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Nuvation Bio Inc. (NUVB-WT) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 50.87, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.30.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -11.32 and a market capitalization of 24.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.72%
5-Day Change
-6.88%
1-Month Change
10.60%
3-Month Change
5.14%
6-Month Change
-66.63%
Year-to-Date (YTD) Change
-78.72%
1-Year Change
-68.78%
3-Year Change
-53.94%
5-Year Change
-53.94%
All-Time (Max) Change
-53.94%

Contact Information

http://www.nuvationbio.com
+1 646 616 2000
1500 Broadway, Suite 1401, New York, NY, 10036

Company Facts

2,200 Employees
IPO DateAug 26, 2020
CountryUS
Actively Trading

Frequently Asked Questions